Kuriyama K, Murakami K, Masuda T, Sugiura K, et al. Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Primary analysis report of a phase 3 open-label trial. Vaccine 2023 May 8:S0264-410X(23)00519-4. doi: 10.1016/j.vaccine.2023.
PMID: 37198021